Metall ZugLTS:0QLX 63 EBIT per Share is CHF-16.62 as of Dec. 2025. GuruFocus rates LTS:0QLX with a GF Score™ of 63/100 and a GF Value™ of CHF784.51 (Fairly Valued). The stock has 3 warning signs investors should review. Among 689 Medical Devices & Instruments companies, Metall Zug ranks worse than 145137.74% on this metric.
Metall Zug's EBIT per Share for the
six
months ended in Dec. 2025 was CHF-14.66.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-16.62.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Metall Zug's EBIT per Share or its related term are showing as below:
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Metall Zug was 9.50% per year. The lowest was -68.10% per year. And the median was -7.20% per year.
LTS:0QLX's 3-Year EBIT Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9.4 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Metall Zug's EBIT for the
six
months ended in Dec. 2025 was CHF-6.6 Mil.
Metall Zug (LTS:0QLX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Metall Zug EBIT per Share Related Terms
Metall Zug EBIT per Share Historical Data
* Premium members only.
The historical data trend for Metall Zug's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-16.62
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metall Zug (LTS:0QLX) has a EBIT per Share of CHF-16.62 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Metall Zug and its competitors. According to the industry distribution chart, Metall Zug ranks #999999 out of 689 companies in the Medical Devices & Instruments industry.
Is Metall Zug's EBIT per Share too high?
Metall Zug's current EBIT per Share is CHF-16.62. Based on the distribution chart, Metall Zug ranks #999999 out of 689 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Metall Zug has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metall Zug's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Metall Zug ranks #999999 out of 689 companies for EBIT per Share. This places Metall Zug in the lower half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Metall Zug and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metall Zug's current EBIT per Share is CHF-16.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metall Zug stock overvalued right now?
Based on GuruFocus' analysis, Metall Zug (LTS:0QLX) is currently considered Fairly Valued. The stock's GF Value™ is CHF784.51, compared to a current price of CHF729.00 — trading 7.1% below its estimated fair value. The current EBIT per Share is CHF-16.62. Metall Zug's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Metall Zug (LTS:0QLX), the current EBIT per Share is CHF-16.62 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metall Zug (LTS:0QLX) Overvalued in 2026?
Based on GuruFocus' analysis, Metall Zug stock appears to be undervalued.
The current stock price of CHF729.00 is trading 7.1% below its estimated GF Value™ of CHF784.51.
GuruFocus considers Metall Zug to be Fairly Valued.
Key valuation signals for LTS:0QLX:
EBIT per Share: CHF-16.62
GF Value™: CHF784.51 vs. price of CHF729.00 (7.1% below fair value)
No single metric tells the full story. See the LTS:0QLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metall Zug Ltd is engaged in the industrial sector. The company is organized, into business segments namely; Medical Devices which comprises of products and services for diagnosis and surgery, mainly in the fields of ophthalmology and microsurgery; Technologycluster & Infrastructure is engaged in Management and development of real estate; and Investments & Corporate. The majority of its revenue is generated from the Medical Devices segment. Geographically, the company operates in Switzerland, Europe (excluding Switzerland), the Americas, and Asia /Pacific/Others, and the majority of its revenue is generated from the Americas region.
63GF Score
Get the complete analysis for LTS:0QLX
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLX has been successfully added to your 
